glp-1 reviews oral Medication Helps Patients Maintain Weight Loss | Newsroom Ifmagic GLP-1 Pro Oral Solution
Description
Some studies and clinical experience suggest that older people on GLP-1s need careful attention to muscle mass and protein intake to avoid functional decline
Boehringer Ingelheim / Zealand Pharma (ZLDPF): Survodutide (aka BI 456906) [44] [44] In a placebo-controlled study evaluating the GLP1R/GR dual agonist (Obesity Indication), patients received weekly subcutaneous injections of 4.8mg for a duration of 46 weeks
are currently taking GLP-1s, according to KFF, and 18% have taken the drugs at some point
Yes, they do lose fat mass and adipose tissue, but it comes at the expense of muscle mass as well
